{"id":{"repo_id":"cornell","oai_identifier":"oai:ecommons.cornell.edu:1813/112010"},"canonical_url":"https://search.ndltd.org/etd/cornell/oai:ecommons.cornell.edu:1813/112010","repository":{"repo_id":"cornell","name":"Cornell University","base_url":"https://ecommons.cornell.edu/server/oai/request"},"display":{"title":"DEVELOPING DEVICES AND TECHNIQUES FOR GLOBAL POINT-OF-CARE DIAGNOSIS OF INFECTIOUS DISEASE AND CANCER","abstract":"One of the largest global healthcare challenges of the 21st century is improving access to adequate diagnostic testing, as emphasized by the SARS-COV-2 pandemic beginning in 2019. This is especially true in limited-resource settings where they lack the traditional healthcare infrastructure that is often necessary for rapid and accurate diagnosis, leaving countless patients undiagnosed and without proper treatment. Nucleic acid testing (NAT) is a molecular approach that can be used to diagnose a variety of pathogenic and genetic diseases through DNA quantification of a specific target, such as viral DNA, within a patient sample. Point-of-care (POC) application of NAT technologies can have powerful impacts globally, but perhaps most significantly in limited-resource settings where deployment of novel devices and methods in a decentralized setting can potentially out-pace the development of traditional healthcare infrastructure.This dissertation details the development of three unique technologies to improve access to rapid and accurate diagnosis through NAT at the point-of-care. The second chapter describes a novel approach to diagnose a viral-borne skin cancer – Kaposi’s sarcoma (KS) – using a POC device, TINY. The third chapter describes an extension of our goal for accessible NAT testing as we describe the development of a high-throughput device for COVID-19 testing, capable of hundreds of samples per day. The fourth chapter will discuss a novel POC device for the rapid extraction of DNA from skin tissue biopsies, further enhancing the POC impact of molecular KS-diagnosis described in the second chapter. All three chapters detail developments for enabling rapid and accurate nucleic acid diagnosis, especially in limited-resource settings, through novel devices and techniques that can be applied at the point-of-care.","abstract_html":"One of the largest global healthcare challenges of the 21st century is improving access to adequate diagnostic testing, as emphasized by the SARS-COV-2 pandemic beginning in 2019. This is especially true in limited-resource settings where they lack the traditional healthcare infrastructure that is often necessary for rapid and accurate diagnosis, leaving countless patients undiagnosed and without proper treatment. Nucleic acid testing (NAT) is a molecular approach that can be used to diagnose a variety of pathogenic and genetic diseases through DNA quantification of a specific target, such as viral DNA, within a patient sample. Point-of-care (POC) application of NAT technologies can have powerful impacts globally, but perhaps most significantly in limited-resource settings where deployment of novel devices and methods in a decentralized setting can potentially out-pace the development of traditional healthcare infrastructure.This dissertation details the development of three unique technologies to improve access to rapid and accurate diagnosis through NAT at the point-of-care. The second chapter describes a novel approach to diagnose a viral-borne skin cancer – Kaposi’s sarcoma (KS) – using a POC device, TINY. The third chapter describes an extension of our goal for accessible NAT testing as we describe the development of a high-throughput device for COVID-19 testing, capable of hundreds of samples per day. The fourth chapter will discuss a novel POC device for the rapid extraction of DNA from skin tissue biopsies, further enhancing the POC impact of molecular KS-diagnosis described in the second chapter. All three chapters detail developments for enabling rapid and accurate nucleic acid diagnosis, especially in limited-resource settings, through novel devices and techniques that can be applied at the point-of-care.","abstract_has_math":false,"creators":["McCloskey, Duncan"],"institution":"Cornell University","degree_name":"Ph. D., Biomedical Engineering","degree_level":"Doctor of Philosophy","degree_discipline":"Biomedical Engineering","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":["Erickson, David"],"committee_members":["Shepherd, Robert F.","Mehta, Saurabh"],"year":2022,"date_issued":"2022-08","date_published":"2022-08","updated_at":"2026-11-19T03:10:05Z","subjects":["cancer","devices","infectious disease","point of care"],"languages":["en"],"rights":["Attribution-NonCommercial 4.0 International"],"rights_urls":["https://creativecommons.org/licenses/by-nc/4.0/"],"identifier_entries":[{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.7298/cbhe-ad48"],"render_values":[{"text":"https://doi.org/10.7298/cbhe-ad48","href":"https://doi.org/10.7298/cbhe-ad48","code":true}]},{"key":"dc:identifier.bibid","label":"Dc Identifier Bibid","values":["15578821"],"render_values":[{"text":"15578821","href":null,"code":true}]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["ProQuest Submission ID: 13153","ProQuest Publication ID: 29258225"],"render_values":[{"text":"ProQuest Submission ID: 13153","href":null,"code":true},{"text":"ProQuest Publication ID: 29258225","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/1813/112010","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/1813/112010","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://ecommons.cornell.edu/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aecommons.cornell.edu%3A1813%2F112010","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.chair","label":"Chair","values":["Erickson, David"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Shepherd, Robert F.","Mehta, Saurabh"]},{"key":"dc:creator","label":"Author","values":["McCloskey, Duncan"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2022-10-31T16:20:25Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2022-10-31T16:20:25Z"]},{"key":"dc:date.issued","label":"Date","values":["2022-08"]},{"key":"dc:relation.uri","label":"Dc Relation URI","values":["https://newcatalog.library.cornell.edu/catalog/15578821"]},{"key":"dc:type","label":"Dc Type","values":["dissertation or thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biomedical Engineering"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Doctor of Philosophy"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph. D., Biomedical Engineering"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Cornell University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["cancer","devices","infectious disease","point of care"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution-NonCommercial 4.0 International"]},{"key":"dc:rights.uri","label":"Rights URI","values":["https://creativecommons.org/licenses/by-nc/4.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.bibid","label":"Dc Identifier Bibid","values":["15578821"]},{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.7298/cbhe-ad48"]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["ProQuest Submission ID: 13153","ProQuest Publication ID: 29258225"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/1813/112010"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"cerif:openaire","label":"Cerif Openaire","values":["<Publication xmlns=\"https://www.openaire.eu/cerif-profile/1.1/\" id=\"4c937f21-58e9-4c42-8f41-45ae3b1dcf69\"> <Type xmlns=\"https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types\">http://purl.org/coar/resource_type/c_1843</Type> <Language>en</Language> <Title>DEVELOPING DEVICES AND TECHNIQUES FOR GLOBAL POINT-OF-CARE DIAGNOSIS OF INFECTIOUS DISEASE AND CANCER</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2022-08</PublicationDate> <DOI>https://doi.org/10.7298/cbhe-ad48</DOI> <Authors> <Author> <DisplayName>McCloskey, Duncan</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <OrgUnit /> </Publisher> </Publishers> <License>https://creativecommons.org/licenses/by-nc/4.0/</License> <Keyword>cancer</Keyword> <Keyword>devices</Keyword> <Keyword>infectious disease</Keyword> <Keyword>point of care</Keyword> <Abstract>One of the largest global healthcare challenges of the 21st century is improving access to adequate diagnostic testing, as emphasized by the SARS-COV-2 pandemic beginning in 2019. This is especially true in limited-resource settings where they lack the traditional healthcare infrastructure that is often necessary for rapid and accurate diagnosis, leaving countless patients undiagnosed and without proper treatment. Nucleic acid testing (NAT) is a molecular approach that can be used to diagnose a variety of pathogenic and genetic diseases through DNA quantification of a specific target, such as viral DNA, within a patient sample. Point-of-care (POC) application of NAT technologies can have powerful impacts globally, but perhaps most significantly in limited-resource settings where deployment of novel devices and methods in a decentralized setting can potentially out-pace the development of traditional healthcare infrastructure.This dissertation details the development of three unique technologies to improve access to rapid and accurate diagnosis through NAT at the point-of-care. The second chapter describes a novel approach to diagnose a viral-borne skin cancer – Kaposi’s sarcoma (KS) – using a POC device, TINY. The third chapter describes an extension of our goal for accessible NAT testing as we describe the development of a high-throughput device for COVID-19 testing, capable of hundreds of samples per day. The fourth chapter will discuss a novel POC device for the rapid extraction of DNA from skin tissue biopsies, further enhancing the POC impact of molecular KS-diagnosis described in the second chapter. All three chapters detail developments for enabling rapid and accurate nucleic acid diagnosis, especially in limited-resource settings, through novel devices and techniques that can be applied at the point-of-care.</Abstract> <Access xmlns=\"http://purl.org/coar/access_right\" > </Access> </Publication>"]},{"key":"cris:virtual.author","label":"Cris Virtual Author","values":["McCloskey, Duncan"]},{"key":"cris:virtualsource.collection","label":"Cris Virtualsource Collection","values":["5893a6ea-7af3-41d7-abc6-04bcd26ab5df"]},{"key":"dc:description","label":"Description","values":["87 pages"]},{"key":"dc:description.abstract","label":"Abstract","values":["One of the largest global healthcare challenges of the 21st century is improving access to adequate diagnostic testing, as emphasized by the SARS-COV-2 pandemic beginning in 2019. This is especially true in limited-resource settings where they lack the traditional healthcare infrastructure that is often necessary for rapid and accurate diagnosis, leaving countless patients undiagnosed and without proper treatment. Nucleic acid testing (NAT) is a molecular approach that can be used to diagnose a variety of pathogenic and genetic diseases through DNA quantification of a specific target, such as viral DNA, within a patient sample. Point-of-care (POC) application of NAT technologies can have powerful impacts globally, but perhaps most significantly in limited-resource settings where deployment of novel devices and methods in a decentralized setting can potentially out-pace the development of traditional healthcare infrastructure.This dissertation details the development of three unique technologies to improve access to rapid and accurate diagnosis through NAT at the point-of-care. The second chapter describes a novel approach to diagnose a viral-borne skin cancer – Kaposi’s sarcoma (KS) – using a POC device, TINY. The third chapter describes an extension of our goal for accessible NAT testing as we describe the development of a high-throughput device for COVID-19 testing, capable of hundreds of samples per day. The fourth chapter will discuss a novel POC device for the rapid extraction of DNA from skin tissue biopsies, further enhancing the POC impact of molecular KS-diagnosis described in the second chapter. All three chapters detail developments for enabling rapid and accurate nucleic acid diagnosis, especially in limited-resource settings, through novel devices and techniques that can be applied at the point-of-care."]},{"key":"dc:description.collection","label":"Dc Description Collection","values":["Cornell Theses and Dissertations"]},{"key":"dc:format.mimetype","label":"Dc Format Mimetype","values":["application/pdf"]},{"key":"dcterms:license","label":"Dcterms License","values":["https://hdl.handle.net/1813/59810.2"]},{"key":"dc:title","label":"Title","values":["DEVELOPING DEVICES AND TECHNIQUES FOR GLOBAL POINT-OF-CARE DIAGNOSIS OF INFECTIOUS DISEASE AND CANCER"]},{"key":"dspace:entity.type","label":"Dspace Entity Type","values":["Publication"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"cerif:openaire":["<Publication xmlns=\"https://www.openaire.eu/cerif-profile/1.1/\" id=\"4c937f21-58e9-4c42-8f41-45ae3b1dcf69\"> <Type xmlns=\"https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types\">http://purl.org/coar/resource_type/c_1843</Type> <Language>en</Language> <Title>DEVELOPING DEVICES AND TECHNIQUES FOR GLOBAL POINT-OF-CARE DIAGNOSIS OF INFECTIOUS DISEASE AND CANCER</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2022-08</PublicationDate> <DOI>https://doi.org/10.7298/cbhe-ad48</DOI> <Authors> <Author> <DisplayName>McCloskey, Duncan</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <OrgUnit /> </Publisher> </Publishers> <License>https://creativecommons.org/licenses/by-nc/4.0/</License> <Keyword>cancer</Keyword> <Keyword>devices</Keyword> <Keyword>infectious disease</Keyword> <Keyword>point of care</Keyword> <Abstract>One of the largest global healthcare challenges of the 21st century is improving access to adequate diagnostic testing, as emphasized by the SARS-COV-2 pandemic beginning in 2019. This is especially true in limited-resource settings where they lack the traditional healthcare infrastructure that is often necessary for rapid and accurate diagnosis, leaving countless patients undiagnosed and without proper treatment. Nucleic acid testing (NAT) is a molecular approach that can be used to diagnose a variety of pathogenic and genetic diseases through DNA quantification of a specific target, such as viral DNA, within a patient sample. Point-of-care (POC) application of NAT technologies can have powerful impacts globally, but perhaps most significantly in limited-resource settings where deployment of novel devices and methods in a decentralized setting can potentially out-pace the development of traditional healthcare infrastructure.This dissertation details the development of three unique technologies to improve access to rapid and accurate diagnosis through NAT at the point-of-care. The second chapter describes a novel approach to diagnose a viral-borne skin cancer – Kaposi’s sarcoma (KS) – using a POC device, TINY. The third chapter describes an extension of our goal for accessible NAT testing as we describe the development of a high-throughput device for COVID-19 testing, capable of hundreds of samples per day. The fourth chapter will discuss a novel POC device for the rapid extraction of DNA from skin tissue biopsies, further enhancing the POC impact of molecular KS-diagnosis described in the second chapter. All three chapters detail developments for enabling rapid and accurate nucleic acid diagnosis, especially in limited-resource settings, through novel devices and techniques that can be applied at the point-of-care.</Abstract> <Access xmlns=\"http://purl.org/coar/access_right\" > </Access> </Publication>"],"cris:virtual.author":["McCloskey, Duncan"],"cris:virtualsource.collection":["5893a6ea-7af3-41d7-abc6-04bcd26ab5df"],"dc:contributor.chair":["Erickson, David"],"dc:contributor.committeemember":["Shepherd, Robert F.","Mehta, Saurabh"],"dc:creator":["McCloskey, Duncan"],"dc:date.accessioned":["2022-10-31T16:20:25Z"],"dc:date.available":["2022-10-31T16:20:25Z"],"dc:date.issued":["2022-08"],"dc:description":["87 pages"],"dc:description.abstract":["One of the largest global healthcare challenges of the 21st century is improving access to adequate diagnostic testing, as emphasized by the SARS-COV-2 pandemic beginning in 2019. This is especially true in limited-resource settings where they lack the traditional healthcare infrastructure that is often necessary for rapid and accurate diagnosis, leaving countless patients undiagnosed and without proper treatment. Nucleic acid testing (NAT) is a molecular approach that can be used to diagnose a variety of pathogenic and genetic diseases through DNA quantification of a specific target, such as viral DNA, within a patient sample. Point-of-care (POC) application of NAT technologies can have powerful impacts globally, but perhaps most significantly in limited-resource settings where deployment of novel devices and methods in a decentralized setting can potentially out-pace the development of traditional healthcare infrastructure.This dissertation details the development of three unique technologies to improve access to rapid and accurate diagnosis through NAT at the point-of-care. The second chapter describes a novel approach to diagnose a viral-borne skin cancer – Kaposi’s sarcoma (KS) – using a POC device, TINY. The third chapter describes an extension of our goal for accessible NAT testing as we describe the development of a high-throughput device for COVID-19 testing, capable of hundreds of samples per day. The fourth chapter will discuss a novel POC device for the rapid extraction of DNA from skin tissue biopsies, further enhancing the POC impact of molecular KS-diagnosis described in the second chapter. All three chapters detail developments for enabling rapid and accurate nucleic acid diagnosis, especially in limited-resource settings, through novel devices and techniques that can be applied at the point-of-care."],"dc:description.collection":["Cornell Theses and Dissertations"],"dc:format.mimetype":["application/pdf"],"dc:identifier.bibid":["15578821"],"dc:identifier.doi":["https://doi.org/10.7298/cbhe-ad48"],"dc:identifier.other":["ProQuest Submission ID: 13153","ProQuest Publication ID: 29258225"],"dc:identifier.uri":["https://hdl.handle.net/1813/112010"],"dc:language.iso":["en"],"dc:relation.uri":["https://newcatalog.library.cornell.edu/catalog/15578821"],"dc:rights":["Attribution-NonCommercial 4.0 International"],"dc:rights.uri":["https://creativecommons.org/licenses/by-nc/4.0/"],"dc:subject":["cancer","devices","infectious disease","point of care"],"dcterms:license":["https://hdl.handle.net/1813/59810.2"],"dc:title":["DEVELOPING DEVICES AND TECHNIQUES FOR GLOBAL POINT-OF-CARE DIAGNOSIS OF INFECTIOUS DISEASE AND CANCER"],"dc:type":["dissertation or thesis"],"dspace:entity.type":["Publication"],"others:access_status":["open.access"],"thesis:degree_discipline":["Biomedical Engineering"],"thesis:degree_level":["Doctor of Philosophy"],"thesis:degree_name":["Ph. D., Biomedical Engineering"],"thesis:institution_name":["Cornell University"]},"updated_at":"2026-11-19T03:10:05Z"}